Schedule 13G ownership disclosure

Silence Therapeutics plc

COMMON STOCK · CUSIP: G8128Y157

Event date: 2026-09-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • FMR LLC

    Shares: 13,180,206.00 · Class: 7.1%

  • Abigail P. Johnson

    Shares: 13,180,206.00 · Class: 7.1%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000315066-26-002833
Form type
SCHEDULE 13G
Filer
Silence Therapeutics plc
CIK
CIK 1479615
Filed
Nov 05, 2026
Reporting period
Sep 30, 2026
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub